ArticleOncoTargets and therapy2025

Efficacy and Safety of Combined PD-1 Inhibitor With Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis.

Kebin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.